Active-ingredient Dossier
Varenicline
Active-ingredient Dossier for Varenicline (nicotine receptor partial agonist). Australian brands, products, PBS listings, PBAC outcomes — compiled by…
- Brand: CHAMPIX
- Brand: VARENICLINE
- Brand: VARENICLINE SANDOZ
- Brand: VARENICLINE VIATRIS
- Brand: VARENIX
- Brand: APO-Varenicline
- Therapeutic area: Psychiatry
What is
Varenicline Varenicline is a nicotine receptor partial agonist.
Australian brands containing
Varenicline — CHAMPIX — VARENICLINE — VARENICLINE SANDOZ — VARENICLINE VIATRIS — VARENIX — APO-Varenicline — APOTEX-Varenicline — ARX-Varenicline — VERINX — VERNIC
Therapeutic areas
Varenicline is registered in psychiatry, with 10 brands containing the ingredient.
Sponsor landscape
Varenicline is marketed by six sponsors: Arrotex Pharmaceuticals, Maple Healthcare, Pfizer, Lupin, Sandoz, and Pharmacor.
PBS and regulatory activity
No varenicline brands currently have PBS-listed items. The latest PBAC outcome on record is from November 2017, with two brands having PBAC outcomes documented. No AusPARs are on record for varenicline.